Evaluation of an Exercise intervention for Vincristine induced peripheral neuropathy in pediatric cancer patients

Exercise Intervention for Peripheral Neuropathy in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients

Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to evaluate the feasibility and acceptability of exercise as an intervention for vincristine-induced peripheral neuropathy in pediatric patients with ALL.

Detailed description of study

The purpose of this study is to evaluate the feasibility and acceptability of exercise as an intervention for vincristine-induced peripheral neuropathy in pediatric patients with ALL.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: acute lymphoblastic leukemia
  • Age: 100 years or below
  • Gender: All
Updated on 19 Feb 2024. Study ID: 1708708583 (PHO-RENBARGER-NIH-EXERCIS)

This study investigates the use of exercise as a treatment for vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia (ALL). Peripheral neuropathy is a condition where nerves are damaged, causing weakness, numbness, and pain, typically in the hands and feet. This study aims to see if exercise can be a feasible and acceptable way to manage these symptoms.

Participants in the study will engage in a structured exercise program. The study will monitor how well participants can follow the exercise routine and how acceptable they find it as part of their treatment plan.

  • Who can participate: This study is for children aged 3 to 18 years diagnosed with acute lymphoblastic leukemia who are experiencing peripheral neuropathy due to vincristine treatment.
  • Study details: Participants will take part in a structured exercise program designed to help manage symptoms of peripheral neuropathy. No placebo will be used in this study.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here